# Trial to Compare the Routes of Administration of an Investigational, Personalized, Therapeutic Cancer Vaccine Oncophage (HSPPC-96) in Patients With Metastatic Renal Cell Carcinoma

> **NCT00082459** · PHASE2 · TERMINATED · sponsor: **Agenus Inc.** · enrollment: 40 (—)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

- **BIOLOGICAL:** autologous human tumor-derived HSPPC-96

## Key facts

- **NCT ID:** NCT00082459
- **Lead sponsor:** Agenus Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-07
- **Primary completion:** 2005-12
- **Final completion:** 2005-12
- **Target enrollment:** 40 (—)
- **Why stopped:** Lack of enrollment
- **Last updated:** 2012-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00082459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00082459, "Trial to Compare the Routes of Administration of an Investigational, Personalized, Therapeutic Cancer Vaccine Oncophage (HSPPC-96) in Patients With Metastatic Renal Cell Carcinoma". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00082459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*